The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents
S Yu, J Zheng, Y Zhang, D Meng, Y Wang, X Xu… - Bioorganic & Medicinal …, 2023 - Elsevier
Chemotherapy is the mainstay in the treatment of breast cancer. However, many drugs that
are commonly used in clinical practice have a high incidence of side effects and multidrug …
are commonly used in clinical practice have a high incidence of side effects and multidrug …
Oestrogen receptor-independent actions of oestrogen in cancer
Oestrogen, the primary female sex hormone, plays a significant role in tumourigenesis. The
major pathway for oestrogen is via binding to its receptor [oestrogen receptor (ERα or β)] …
major pathway for oestrogen is via binding to its receptor [oestrogen receptor (ERα or β)] …
Design, synthesis, and in‐silico study of novel triarylethylene analogs with dual anti‐estrogenic and serotonergic activity
Estrogen receptor is an important target in breast cancer. Serotonin receptors (5‐HT2A and
5‐HT2C, in particular) were investigated for a potential role in development and progression …
5‐HT2C, in particular) were investigated for a potential role in development and progression …
[HTML][HTML] Prognostic role of serum soluble ST2 of advanced breast cancer patients: a retrospective cohort study
C Chen, J Li, L Rossi, P Sun, T She… - Translational Cancer …, 2023 - ncbi.nlm.nih.gov
Background The soluble suppression of tumorigenicity 2 receptor (sST2) binds to interleukin-
33 (IL-33) and blocks IL-33 and ST2 binding, suggesting that sST2 acts as a “decoy” …
33 (IL-33) and blocks IL-33 and ST2 binding, suggesting that sST2 acts as a “decoy” …